Health Canada approves Novo Nordisk’s obesity drug to reduce risk of non-fatal heart attack

Wegovy injections approved by Health Canada.

Canada’s health regulator has approved Novo Nordisk’s weight loss drug Wegovy to reduce the risk of nonfatal heart attack or myocardial infarction in some adults

Full Article

via YO SEO TOOLS

Avatar

By Icanada

Related Post

Leave a Reply

Your email address will not be published. Required fields are marked *